Lupus Clinical Trials in Oklahoma

13 recruiting studies across 1 city

Browse by City

All Trials in Oklahoma

Phase

Trial	Phase	Sponsor	Dist.
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)	—	Hospital for Special Surgery, New York	<1 mi
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine	Phase 2	State University of New York - Upstate Medical University	<1 mi
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)	Phase 2	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial	Phase 4	NephroNet, Inc.	<1 mi
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus	Phase 3	AbbVie	<1 mi
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease	Phase 3	NYU Langone Health	<1 mi
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus	Phase 3	Viatris Innovation GmbH	<1 mi
Safety of the Herpes Zoster Subunit Vaccine in Lupus	Phase 4	NYU Langone Health	<1 mi
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus	Phase 2	Zenas BioPharma (USA), LLC	<1 mi
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132	Phase 4	Bristol-Myers Squibb	<1 mi
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease	Phase 1	Fate Therapeutics	<1 mi
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants	—	Bristol-Myers Squibb	<1 mi
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus	Phase 2	Sanofi	<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.